As returns on market increase, returns on owning Avanir are expected to decrease at a much smaller rate. During bear market, Avanir is likely to outperform the market.
Keith Katkin CEO and President Director and Member of Executive Committee
Craig Wheeler Independent Chairman of the Board, MBA
Randall Kaye Senior Vice President Chief Medical Officer
Joao Siffert Senior Vice President - Research and Development, MBA
Avanir Price and Market Media
The median price of Avanir for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 3.25 with a coefficient of variation of 3.13. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 3.24, and mean deviation of 0.09. The Stock received some media coverage during the period.
Avanir Pharmaceuticals Inc [AVNR] is traded on NASDAQ in USA. It is located in Avanir Pharmaceuticals, Inc.Aliso Viejo, CA and employs 225 people. The company currently falls under 'Small-Cap' category with current market capitalization of 471.6 M. Avanir Pharmaceuticals Inc conducts business under Healthcare sector and is part of Drugs - Generic industry. This company has 145.11 M outstanding shares of which 20.28 M shares are presently shorted by private and institutional investors with about 14.2 trading days to cover.
Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic solutions for the treatment of central nervous system disorders primarily in the United States. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Nasdaq
